News

Indian shares ended in the red on Friday, dragged down by a combination of weak global cues, sustained foreign fund outflows, ...
The NSE-listed pharma stock gained nearly 1% to hit the day's high of ₹48.35. However, the stock still trades at a one-third ...
Indian markets face uncertainty with slowing earnings growth, but Mukherjea remains optimistic about US-India trade deal ...
Shripal Shah, MD & CEO of Kotak Securities, shares his views on where the Indian equity market stands amid global uncertainty ...
Ravi Dharamshi believes that even in a mega trend of a business cycle, one needs to be invested in a 'growth phase' for ...
The US tariff announcement came after the markets closed and could result in investors taking fresh bearish positions.
India's strong 6.4% projected GDP growth and favorable demographics make it an attractive emerging market opportunity, ...
With an average price-to-earnings ratio of 23.52, the Indian stock market ranks among the world's most expensive, below the U.S. at 25.41 but far exceeding China's 12.00.
So far, 2025 hasn't been a great year for growth stocks. At the time of this writing, the growth-heavy Nasdaq Composite is down by more than 10% year to date -- underperforming the S&P 500 and Dow ...